Impax Asset Management Group plc lifted its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 28.0% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 618,415 shares of the semiconductor company’s stock after purchasing an additional 135,198 shares during the period. Synopsys accounts for 1.8% of Impax Asset Management Group plc’s holdings, making the stock its 11th biggest position. Impax Asset Management Group plc owned about 0.40% of Synopsys worth $315,663,000 as of its most recent filing with the Securities & Exchange Commission.
Other large investors have also recently added to or reduced their stakes in the company. Hemington Wealth Management lifted its stake in shares of Synopsys by 10.1% in the 2nd quarter. Hemington Wealth Management now owns 197 shares of the semiconductor company’s stock valued at $100,000 after acquiring an additional 18 shares during the last quarter. Concord Asset Management LLC VA increased its stake in Synopsys by 0.8% in the 2nd quarter. Concord Asset Management LLC VA now owns 2,379 shares of the semiconductor company’s stock valued at $1,220,000 after buying an additional 18 shares during the last quarter. Rehmann Capital Advisory Group increased its position in shares of Synopsys by 1.4% during the 2nd quarter. Rehmann Capital Advisory Group now owns 1,345 shares of the semiconductor company’s stock valued at $690,000 after purchasing an additional 18 shares during the last quarter. MCF Advisors LLC raised its holdings in shares of Synopsys by 16.2% in the 2nd quarter. MCF Advisors LLC now owns 136 shares of the semiconductor company’s stock worth $70,000 after purchasing an additional 19 shares during the period. Finally, Savvy Advisors Inc. lifted its holdings in Synopsys by 3.6% during the second quarter. Savvy Advisors Inc. now owns 551 shares of the semiconductor company’s stock valued at $282,000 after purchasing an additional 19 shares during the last quarter. Institutional investors own 85.47% of the company’s stock.
Synopsys Stock Up 0.8%
Shares of SNPS stock opened at $398.81 on Thursday. The company has a current ratio of 1.62, a quick ratio of 1.51 and a debt-to-equity ratio of 0.52. Synopsys, Inc. has a 12 month low of $365.74 and a 12 month high of $651.73. The stock has a market cap of $74.08 billion, a P/E ratio of 31.30, a P/E/G ratio of 5.02 and a beta of 1.10. The company has a 50 day simple moving average of $463.30 and a two-hundred day simple moving average of $514.08.
Insider Buying and Selling
In other news, CEO Sassine Ghazi sold 11,366 shares of Synopsys stock in a transaction dated Tuesday, September 2nd. The stock was sold at an average price of $589.01, for a total transaction of $6,694,687.66. Following the transaction, the chief executive officer directly owned 71,615 shares of the company’s stock, valued at $42,181,951.15. The trade was a 13.70% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Sudhindra Kankanwadi sold 9,873 shares of the stock in a transaction that occurred on Monday, September 22nd. The stock was sold at an average price of $500.90, for a total transaction of $4,945,385.70. Following the completion of the sale, the chief accounting officer directly owned 20,520 shares of the company’s stock, valued at $10,278,468. This represents a 32.48% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 30,894 shares of company stock valued at $16,760,783 in the last 90 days. Corporate insiders own 0.62% of the company’s stock.
Analyst Upgrades and Downgrades
SNPS has been the subject of several recent analyst reports. Mizuho reduced their price objective on shares of Synopsys from $700.00 to $600.00 and set an “outperform” rating for the company in a research note on Thursday, September 11th. Wells Fargo & Company cut their price objective on shares of Synopsys from $630.00 to $550.00 and set an “equal weight” rating for the company in a research note on Wednesday, September 10th. BNP Paribas started coverage on Synopsys in a research note on Thursday, October 2nd. They issued an “underperform” rating and a $425.00 price target on the stock. Needham & Company LLC dropped their target price on shares of Synopsys from $660.00 to $550.00 and set a “buy” rating for the company in a report on Wednesday, September 10th. Finally, Zacks Research upgraded Synopsys from a “strong sell” rating to a “hold” rating in a report on Monday. Nine research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $562.14.
Read Our Latest Research Report on Synopsys
About Synopsys
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
See Also
- Five stocks we like better than Synopsys
- How to Calculate Inflation Rate
- 3 Reasons On Holding’s Sell-Off Is Over and New Highs Are Coming
- High Dividend REITs: Are They an Ideal Way to Diversify?
- As Warren Buffett Nears His Exit, Berkshire’s Amassed Record Cash
- What Do S&P 500 Stocks Tell Investors About the Market?
- Rare Earth Stocks: The Truce That Isn’t a Truce
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
